Sodium Hyaluronate-based Products Market – By Product (Topical, Injectable), Application (Pharmaceuticals [Dermatology, Ophthalmology, Orthopedic, Urology], Cosmetics), End-use (Hospitals, ASC) – Global Forecast 2024 – 2032

Sodium Hyaluronate-based Products Market Size

Sodium Hyaluronate-Based Products Market size was valued at around USD 11.3 billion in 2023 and is anticipated to register a CAGR of 7.8% between 2024 and 2032. This robust market growth can be attributed to various factors, including ongoing advancements in formulation technologies, rising demand for anti-aging products, an increasing prevalence of skin disorders, growing aging population, and increasing awareness about skincare and wellness, among other contributing factors.

To get key market trends

  Download Free Sample

As we age, our skin and body change. Wrinkles, dry skin, and joint pain become more common. That's why there's a growing demand for products that help us deal with these age-related issues. Sodium hyaluronate is a natural substance that's found in our skin and joints. It's a powerful moisturizer and lubricant, which makes it a great ingredient for anti-aging products and treatments for joint pain and eye problems. For example, doctors use sodium hyaluronate to help treat joint pain by injecting it into the knee. It can also be used in eye drops to treat dry eyes. As the world's population ages, the demand for sodium hyaluronate is only going to grow. By 2050, there are expected to be over 1.6 billion people over the age of 65. That's 16% of the world's population! So it's no wonder that we're seeing more products on the market that contain sodium hyaluronate.

Furthermore, advances in formulation technologies have enabled the development of innovative skincare products with enhanced delivery systems and improved efficacy. Manufacturers are incorporating sodium hyaluronate into various formulations such as serums, creams, masks, and injectables, offering consumers a diverse range of options to address their skincare needs, thereby contributing to the market growth.

Sodium hyaluronate-based products are formulations that contain sodium hyaluronate as a key active pharmaceutical ingredients. Sodium hyaluronate, also known as hyaluronic acid, is a naturally occurring polysaccharide found in the human body, particularly in connective tissues, skin, and eyes. It plays a crucial role in maintaining tissue hydration, lubrication, and elasticity.
 

What are the growth opportunities in this market?

 Download Free Sample

Sodium Hyaluronate-based Products Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous innovations in delivery systems, rise in demand for natural and organic products, growing focus on customization and personalization of skincare solutions, and expansion of medical and therapeutic applications, among other factors are propelling the industry growth.

• Further, there is a growing preference among consumers for natural and organic skincare products, including those containing sodium hyaluronate. As awareness of ingredient safety and environmental sustainability increases, manufacturers are responding by formulating products with clean, plant-based, and ethically sourced ingredients.
• Moreover, technological innovations are driving the development of novel drug delivery systems for sodium hyaluronate-based products. Nanotechnology, microencapsulation, and liposomal delivery systems enhance the bioavailability and efficacy of hyaluronic acid formulations, allowing for deeper penetration into the skin and prolonged release of active ingredients.

Sodium Hyaluronate-based Products Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

The market by product is categorized into injectable, topical, and other products. The injectable segment garnered USD 9.7 billion revenue in 2023.

• There's a growing demand for cosmetic procedures to cure aging symptoms including wrinkles, volume loss, and face sagging as the global population grows older. Injectable sodium hyaluronate-based dermal fillers are a non-surgical option for individuals seeking to restore face volume, smooth wrinkles, and achieve a more youthful appearance.
• Furthermore, injectable sodium hyaluronate-based fillers are considered minimally invasive procedures compared to surgical interventions, appealing to individuals seeking cosmetic enhancements with minimal downtime and recovery. The convenience, safety, and relatively low risk associated with dermal fillers contribute to their popularity among patients and healthcare providers alike.

Learn more about the key segments shaping this market

 Download Free Sample

Based on application, the sodium hyaluronate-based products market is segmented into pharmaceuticals, and cosmetics. The pharmaceuticals segment is further bifurcated into ophthalmology, orthopedic, dermatology, urology, and other pharmaceuticals. The pharmaceuticals segment accounted for over 69% business share in 2023 and is anticipated to witness highest growth.

• The prevalence of ophthalmic diseases such as dry eye syndrome, cataracts, and ocular surface diseases is on the rise, owing to the factors such as aging populations, environmental contaminants, and digital gadget use. Sodium hyaluronate-based ophthalmic treatments lubricate, hydrate, and protect the ocular surface, relieving dry eyes and other ocular diseases. For instance, according to the American Academy of Ophthalmology, approximately 2.5 million eye injuries occur in the U.S. annually.
• Moreover, pharmaceutical-grade sodium hyaluronate is a key ingredient in dermal fillers, wound dressings, and medical devices used in dermatology and wound care. Injectable dermal fillers containing hyaluronic acid are utilized for facial augmentation, scar revision, and soft tissue contouring, while hyaluronate-based wound dressings promote wound healing, tissue regeneration, and moisture management in acute and chronic wounds, thereby fostering segmental growth in the market.

The sodium hyaluronate-based products market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 6.6 billion revenue size in 2023.

• Hospitals are primary settings for various surgical procedures and medical interventions where sodium hyaluronate-based products are utilized. In ophthalmology, sodium hyaluronate is used in intraocular surgeries such as cataract extraction and intraocular lens implantation, where ophthalmic viscosurgical devices (OVDs) help maintain intraocular pressure and protect delicate ocular tissues.
• Additionally, hospitals provide comprehensive post-surgical care and wound management services, where sodium hyaluronate-based dressings and gels are employed to promote wound healing, tissue regeneration, and moisture retention. Hyaluronic acid-based wound care products create a moist environment conducive to healing, minimize scarring, and reduce the risk of infection in acute and chronic wounds.

Looking for region specific data?

 Download Free Sample

North America sodium hyaluronate-based products market accounted for USD 4.5 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• North America boasts a thriving skincare and cosmetic industry, characterized by product innovation, technological advancements, and consumer-driven trends. Sodium hyaluronate is a key ingredient in many skincare and cosmetic formulations, including moisturizers, serums, masks, and dermal fillers, catering to diverse consumer preferences and aesthetic needs.
• Furthermore, non-invasive aesthetic treatments, including injectable dermal fillers and minimally invasive procedures, are increasingly popular in the region, driven by factors such as convenience, minimal downtime, and natural-looking results. Sodium hyaluronate-based dermal fillers offer safe, effective, and customizable solutions for patients seeking facial rejuvenation, volume enhancement, and contouring without undergoing surgical procedures, leading to the regional growth.

Sodium Hyaluronate-based Products Market Share

The sodium hyaluronate-based products industry is competitive in nature, with several large multinationals, small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including ASHLAND INC., Allergan, Inc., Anika Therapeutics, Inc, GALDERMA, Zimmer Biomet, among others have a notable presence in the market.

Sodium Hyaluronate-based Products Market Companies

Some of the eminent market participants operating in the sodium hyaluronate-based products industry include

• ASHLAND INC.
• Allergan, Inc.
• Anika Therapeutics, Inc
• Bohus BioTech AB
• Cadila Pharmaceuticals
• Ferring B.V.
• Fidia Farmaceutici S.p.A.
• GALDERMA
• LG Chem, Ltd.
• Syner-Med (Pharmaceutical Products) Ltd.
• Zimmer Biomet

Sodium Hyaluronate-based Products Industry News

• In June 2023, Galderma announced that the U.S. Food and Drug Administration (FDA) granted approval for Restylane Eyelight for the treatment of undereye hollows, commonly known as dark shadows, in individuals over the age of 21. It is an undereye hyaluronic acid (HA) dermal filler that treats volume loss under the eyes and provides patients with natural-looking results.
• In January 2023, Ashland announced the launch of the Hyalurotech sodium hyaluronate line, which includes sodium hyaluronate in various molecular weights. This new product offers a variety of possibilities for customizing skincare. The differing molecular weights allow for numerous levels of penetration into the skin, making it appropriate for use on multiple areas of the face and body.

Sodium hyaluronate-based products market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Injectable
• Topical
• Other products

Market, By Application

• Pharmaceuticals
  • Ophthalmology
  • Orthopedic
  • Dermatology
  • Urology
  • Other pharmaceuticals 
• Cosmetics

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa